The phase II Proof of Concept (COMB study protocol has been published at PLOS ONE, an inclusive journal community for research in science and medicine. This is an important step in the [...]
At the 36th ECNP Congress in Barcelona Spain October 6-10, 2023, Professor Bo Söderpalm, Addiction Biology Unit, Institute of Neuroscience and Physiology, University of Gothenburg, Sweden, [...]
Sobrera Pharma AB, a Swedish pharmaceutical company developing therapies for treatment and prevention of Alcohol Use Disorder (AUD), today announced successful results from a Phase 2 trial [...]
The United States Patent and Trademark Office (USPTO) has granted a new patent US 11,318,143 further strengthening the Company’s Intellectual property position and coverage for the Company’s [...]
